$ cat ./records/gates-foundation-grants-50-million-to-psi-for-voluntary-male-circ-2009.txt
Gates Foundation Grants $50 Million to PSI for Voluntary Male Circumcision in Southern Africa
[RECORD.TXT] · cat --full
The Gates Foundation awarded $50 million over five years to Population Services International (PSI) to scale voluntary medical male circumcision (VMMC) programmes in Swaziland, Zambia, and other Southern African countries. Clinical trials had demonstrated that VMMC reduces female-to-male HIV transmission by 60 percent, making it one of the most cost-effective HIV prevention interventions available. PSI's Gates-funded VMMC programmes trained surgical teams, ran demand-generation campaigns, and achieved hundreds of thousands of procedures annually at safe government sites.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Commits $60 Million to Monash University to Launch World Mosquito Program
Next →
Gates Foundation Funds Pneumococcal Vaccine Introduction Across Gavi-Eligible Countries
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.